IQV:NYSE
Iqvia Holdings Inc
$266.35
arrow_downward
-0.93%(-2.50) 1D
Oct 1, 10:07:03 AM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IQV...
Open
$268.02
High
$268.88
Low
$265.87
Mkt. cap
43.84B
Avg. vol.
1.53M
Volume
50.53K
P/E ratio
33.02
52-wk high
$277.40
52-wk low
$154.50
EPS
$8.07
Beta
1.18
Shares outstanding
164.60M
No. of employees
94K
Open
$268.02
High
$268.88
Low
$265.87
Mkt. cap
43.84B
Avg. vol.
1.53M
Volume
50.53K
P/E ratio
33.02
52-wk high
$277.40
52-wk low
$154.50
EPS
$8.07
Beta
1.18
Shares outstanding
164.60M
No. of employees
94K
News stories
From web sources and news partners
Simply Wall St
·
1 day ago
Is IQVIA Holdings (IQV) Reasonable After A 42% 1 Year Run?
Yahoo Finance
·
1 day ago
IQVIA Holdings, Inc. (IQV) Stock Forecasts
GuruFocus
·
2 days ago
IQV Maintains Rating by RBC Capital -- Price Target Raised to $3
About Iqvia Holdings Inc
CEO-
Employees94K
Founded-
HeadquartersDenver, Colorado, United States
SectorHealth care
Websiteiqvia.com
Analyst ratings
Based on 16 analysts giving stock ratings to IQV in the past 3 months
Strong buy
Buy
15
Hold
1
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for IQV in the last 3 months.
Highest
Current $266.35
$345.00 (+29.53%)
Average
$286.93 (+7.73%)
Lowest
$240.00 (-9.89%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Kevin Caliendo UBS | Buy | Initiated | $345.00 | +29.5% | 09/30/2026 |
Ryan Halsted RBC Capital | Buy | Reiterated | $319.00 | +19.8% | 09/29/2026 |
Jailendra Singh Truist Financial | Buy | Reiterated | $329.00 | +23.5% | 09/28/2026 |
Kallum Titchmarsh Morgan Stanley | Hold | Reiterated | $270.00 | +1.4% | 09/17/2026 |
Elizabeth Anderson CFA Evercore ISI | Buy | Maintained | $275.00 | +3.2% | 08/12/2026 |
Ann Hynes Mizuho Securities | Buy | Maintained | $275.00 | +3.2% | 07/31/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $290.00 | +8.9% | 07/29/2026 |
Sean Dodge BMO Capital | Buy | Maintained | $270.00 | +1.4% | 07/29/2026 |
Anne Samuel J.P. Morgan | Buy | Reiterated | $285.00 | +7% | 07/29/2026 |
Casey Woodring J.P. Morgan | Buy | Reiterated | $285.00 | +7% | 07/29/2026 |
Shlomo Rosenbaum Stifel Nicolaus | Buy | Maintained | $276.00 | +3.6% | 07/29/2026 |
Eric Coldwell Robert W. Baird | Buy | Maintained | $287.00 | +7.8% | 07/29/2026 |
Michael Ryskin Bank of America Securities | Buy | Reiterated | $280.00 | +5.1% | 07/28/2026 |
Charles Rhyee TD Cowen | Buy | Reiterated | $288.00 | +8.1% | 07/29/2026 |
Luke Sergott Barclays | Buy | Maintained | $275.00 | +3.2% | 07/29/2026 |
Jared Haase William Blair | Buy | Reiterated | - | - | 07/28/2026 |
Sidharth Sahoo HSBC | Buy | Maintained | $240.00 | -9.9% | 07/06/2026 |
David Toung Argus Research | Buy | Maintained | - | - | 05/29/2026 |
Max Smock William Blair | Buy | Reiterated | - | - | 05/05/2026 |
Patrick B Donnelly Citi | Hold | Reiterated | $200.00 | -24.9% | 04/07/2026 |
David Windley Jefferies | Buy | Maintained | $255.00 | -4.3% | 02/06/2026 |
Dan Leonard UBS | Buy | Maintained | $240.00 | -9.9% | 02/06/2026 |
David Larsen BTIG | Hold | Maintained | - | - | 02/05/2026 |
Last report
Jul 28, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$3.15 / $3.03
+3.94%beat
arrow_upward
Revenue / Est. (USD)
4.37B / 4.30B
+1.53%beat
arrow_upward
Fiscal Q2 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 4.10B | 4.36B | 4.15B | 4.37B |
Cost of goods sold | 2.73B | 2.93B | 2.80B | 2.93B |
Cost of revenue | 2.73B | 2.93B | 2.80B | 2.93B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 514.00M | 457.00M | 502.00M | 574.00M |
Operating expense | 800.00M | 774.00M | 790.00M | 866.00M |
Total operating expenses | 3.53B | 3.70B | 3.59B | 3.80B |
Operating income | 573.00M | 662.00M | 565.00M | 569.00M |
Other non operating income | 31.00M | 21.00M | -5.00M | -12.00M |
EBT including unusual items | 408.00M | 573.00M | 334.00M | 318.00M |
EBT excluding unusual items | 428.00M | 537.00M | 384.00M | 384.00M |
Income tax expense | 76.00M | 59.00M | 59.00M | 60.00M |
Effective tax rate | 18.63% | 10.30% | 17.66% | 18.87% |
Other operating expenses | - | - | - | - |
Net income | 331.00M | 514.00M | 274.00M | 256.00M |
Net profit margin | 8.07% | 11.78% | 6.60% | 5.86% |
Earnings per share | 3.00 | 3.42 | 2.90 | 3.15 |
Interest and investment income | 13.00M | 11.00M | 10.00M | 7.00M |
Interest expense | -189.00M | -193.00M | -192.00M | -197.00M |
Net interest expenses | -176.00M | -182.00M | -182.00M | -190.00M |
Depreciation and amortization charges | 286.00M | 317.00M | 288.00M | 292.00M |
EBITDA | 859.00M | 979.00M | 853.00M | 861.00M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1